SecBot SecBot

ARAY

ACCURAY INC
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001138723 Healthcare & Medical Devices
$0.1326 +0.01 (+10.50%)
Oct 27 4:00 PM ET · prev $0.1200
Market cap
$15.6M
Nano cap
Median target
$0.3500
+164% · range $0.3500–0.3500
Next earnings
Nov 4
in 8 days
1 year
−91.4%
from $1.55 · Oct 27
30 days
−55.8%
from $0.3000
52-week range
$0.1200–1.55
−91% from high · low Oct 26
Avg volume 20D
2.35M
shares / day
Short interest
🔒 Subscribers only
Insider net
+$134.7K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
14
analyzed by SecBot
SecBot read BEARISH 11 reports · 90 days
Balance 5 bearish · 0 bullish · 1 mixed · 5 neutral oldest → newest, height = score
Avg score ·High conf. 8/11 ·Next Earnings date, Nov 4, 2026
Strongest BEARISH Accuray's 2026 proxy statement reveals a company in distress: revenue fell to $401.9M (80% of target)…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $134.7K at an average $0.5387. No open-market sales. Price is 75% below their cost.

  • InstitutionsMIXED

    Q2 2026: 16 added (0 new), 13 trimmed or exited.

  • TrendDOWNTREND

    43% below its 50-day average. New closing low $0.1200 on Oct 26.

  • SocialQUIET

    No Reddit mentions this week. Last mention Sep 28.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.TRIM3,266,185$842.0K
Squarepoint Ops LLCDOUBLED1,448,234$373.4K
GEODE CAPITAL MANAGEMENT, LLCTRIM1,189,377$306.7K
SUSQUEHANNA INTERNATIONAL GROUP, LLPDOUBLED825,604$212.8K
STATE STREET CORPNEAR_EXIT485,866$125.3K
TUDOR INVESTMENT CORP ET ALADD392,236$101.1K
JPMORGAN CHASE & CODOUBLED376,695$97.8K
IEQ CAPITAL, LLCDOUBLED333,267$85.9K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2026
12-month targets · 1 analysts

Price is below the lowest target. Median implies +164%.Targets as of Sep 22, 2026.

Recent actions
DateFirmActionRating
May 12, 2026Jefferies
DOWNGRADE
DOWNGRADEHold
May 7, 2026BTIG
DOWNGRADE
DOWNGRADENeutral
Reddit
Recent posts
r/pennystocks Neutral 29d ago
28 SEPTEMEBER 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
1 upvotes · 6 comments
All social signals and their track records

Insider ledger

Form 4
$134.7K
bought · 1 insider
$0
sold · 0 insiders
−75.4%
vs their $0.5387 cost
DateInsiderTypeValue
Oct 5, 2026
MEIER RICHARD A
Director
AWARD75,000 sh
Oct 5, 2026
MEIER RICHARD A
Director
AWARD75,000 sh
Sep 23, 2026
Pervaiz Ali
SVP Chief Financial Officer
AWARD19,811 sh
Sep 23, 2026
Pervaiz Ali
SVP Chief Financial Officer
TAX W/H$2.0K
Jul 29, 2026
TCW GROUP INC
10%+ Owner
OTHER598,114 sh
Jul 29, 2026
TCW GROUP INC
10%+ Owner
OTHER7,987,743 sh
May 29, 2026
Miele Paul Michael
SVP, Chief Commercial Officer
AWARD650,000 sh
May 19, 2026
TCW GROUP INC
10%+ Owner
OTHER1,010,028 sh

Earnings setup

Estimates
Nov 4
reports in 8 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Washington

Corporate Lobbying

11 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 21, 2026 SEC
Accuray Incorporated announced it will report its fiscal Q1 2027 results on November 4, 2026.
PRESS-RELEASE — Impact 1/10
Oct 21, 2026 Earnings
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
MADISON, Wis., Oct. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financi
Oct 16, 2026 SEC
Accuray's 2026 proxy statement reveals a company in distress: revenue fell to $401.9M (80% of target), orders hit…
DEF 14A — Impact 6/10
Oct 13, 2026 SEC
Director Mika Nishimura will not stand for re-election at Accuray's 2026 annual meeting in November, citing no…
8-K — Impact 4/10
Oct 5, 2026 Insider
MEIER RICHARD A was granted 75,000 shares
Director
Oct 5, 2026 Insider
MEIER RICHARD A was granted 75,000 shares
Director
Sep 27, 2026 Press
Accuray announced a collaboration with Samsung NeuroLogica to develop advanced volumetric imaging capabilities for the…
Impact 3/10
Sep 23, 2026 Insider
Pervaiz Ali was granted 19,811 shares
SVP Chief Financial Officer
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 4, 2026
Earnings date
ARAY Q1 2027 Earnings Scheduled — 2026-11-04
Recent
Oct 21, 2026
Earnings
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
MADISON, Wis., Oct. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year…
Oct 15, 2026
Short interest
🔒 Fresh data, subscribers only
Sep 30, 2026
Short interest
Short Interest: ARAY up 50% to 7.4M shares
Settlement 2026-09-30 | Days to cover: 1.00 | ≈6.19% of shares outstanding (est.)
Sep 27, 2026
Contract
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
MADISON, Wis., Sept. 27, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that it had entered into agreements with Samsung…
Sep 11, 2026
M&A
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
MADISON, Wis., Sept. 11, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer…

SecBot reports

14 filings · 2 press releases · 0 bullish · 5 bearish · 1 mixed · 8 neutral
All ARAY filing & press-release reports (16)